- £194.65bn
- £215.55bn
- $45.81bn
- 79
- 11
- 96
- 69
REG - AstraZeneca PLC - Acquisition of Fusion completed
AnnouncementREG - AstraZeneca PLC - Block listing Interim Review
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Tagrisso plus chemo recommended for approval in EU
AnnouncementREG - AstraZeneca PLC - Dato-DXd improved OS in nonsquamous lung cancer
AnnouncementREG - AstraZeneca PLC - AstraZeneca to deliver $80bn revenue by 2030
AnnouncementREG - AstraZeneca PLC - AstraZeneca to manufacture ADCs in Singapore
AnnouncementREG - AstraZeneca PLC - SUPERNOVA Trial Met COVID-19 prevention endpoint
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - AstraZeneca completes Cellectis equity investment
AnnouncementREG - AstraZeneca PLC - Calquence combination improved PFS in 1L MCL
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - 1st Quarter Results
AnnouncementREG - Stock Exch Notice - Admission to ISM - 17/04/2024
AnnouncementREG - AstraZeneca PLC - Result of AGM
AnnouncementREG - AstraZeneca PLC - AstraZeneca increases 2024 dividend by 7%
AnnouncementREG - AstraZeneca PLC - Enhertu approved in US for HER2+ solid tumours
AnnouncementREG - AstraZeneca PLC - Imfinzi improved OS & PFS in limited-stage SCLC
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
Announcement